Wai Chun Bio-Technology Limited (HKG:0660)

Wai Chun Bio-Technology Ratios and Metrics

Market cap in millions HKD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 9, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Dec 31, 2021
Market Capitalization	43	25	21	17	67	94
Market Cap Growth	242.19%	14.91%	22.55%	-73.98%	-28.57%	-29.96%
Enterprise Value	190	156	148	152	219	232
Last Close Price	0.24	0.14	0.13	0.10	0.40	0.56
PS Ratio	0.08	0.07	0.06	0.02	0.10	0.19
PB Ratio	-1.24	-0.39	-0.39	1.66	11.14	-3.96
P/FCF Ratio	-	-	1.78	0.84	-	-
P/OCF Ratio	-	17.33	0.41	0.36	21.10	-
EV/Sales Ratio	0.33	0.41	0.40	0.20	0.33	0.47
EV/EBITDA Ratio	11.28	10.29	13.76	7.10	8.97	30.22
EV/EBIT Ratio	30.23	41.83	91.49	12.78	12.18	142.65
EV/FCF Ratio	-	-	12.30	7.35	-	-
Debt / Equity Ratio	-4.09	-1.52	-2.46	12.75	25.06	-6.20
Debt / EBITDA Ratio	8.42	5.63	10.47	5.17	5.25	12.36
Debt / FCF Ratio	-	-	11.28	6.49	-	-
Net Debt / Equity Ratio	-3.40	-1.41	-2.42	12.15	23.81	-5.13
Net Debt / EBITDA Ratio	7.00	5.85	12.43	5.97	5.88	15.92
Net Debt / FCF Ratio	-	-3.67	11.10	6.18	-17.96	-12.58
Asset Turnover	2.80	1.78	1.65	3.16	-	2.64
Inventory Turnover	13.30	5.36	4.83	8.34	-	7.71
Quick Ratio	0.40	0.14	0.13	0.31	0.33	0.29
Current Ratio	0.67	0.39	0.45	0.81	0.86	0.60
Return on Equity (ROE)	-	-	-	-121.40%	-	-
Return on Assets (ROA)	1.93%	1.10%	0.45%	3.04%	-	0.54%
Return on Invested Capital (ROIC)	7.54%	7.14%	1.49%	8.27%	-5.34%	1.55%
Return on Capital Employed (ROCE)	14.40%	-6.00%	-3.70%	14.60%	25.10%	5.40%
Earnings Yield	-16.11%	-59.37%	-206.27%	-88.24%	-21.36%	-18.09%
FCF Yield	-	-97.93%	56.20%	118.42%	-11.91%	-10.31%
Buyback Yield / Dilution	-3.19%	-1.15%	-1.51%	-0.78%	-0.14%	-0.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.